Says respond else face action Annoyed by the non-submission of reports regarding illegal clinical trials of breast cancer drug, the National Human Rights Commission (NHRC) has issued notices to the Union health ministry and the Andhra Pradesh government. It has asked the Centre and the state government to respond within six weeks or face action. The commission had in June last year sent notices to the Union health secretary, secretary of the...

India's decision this month to produce Germany-based multinational Bayer's anti-cancer drug Nexavar, in the first use of "compulsory licensing" in South Asia, will save lives but also raises intricate questions. Under the compulsory licensing process, a government can under World Trade Organization (WTO) rules bypass a patent owner's rights after three years and order the manufacture and sale of life-saving medicines at much cheaper cost than by obtaining the medicine from...

-The Telegraph Lakshman Seth, the former CPM member of Parliament blamed for much of the bloodshed in Nandigram, was arrested by a Bengal police team this afternoon while hiding in a Mumbai guesthouse along with two party colleagues. Seth, former MLA Amiya Sahoo and East Midnapore leader Ashok Guria are the key accused in the alleged killing of six villagers during the CPM’s “recapture” of Nandigram in November 2007. Seth, entangled in...

-PTI The UIDAI's Aadhaar project for providing unique identity numbers to residents, has huge potential to improve the delivery of social sector schemes like rural employment guarantee, the Economic Survey 2011-12 said. "Aadhaar has huge potential for improving operations and delivery of services," the survey said. The Unique Identification Authority of India (UIDAI), attached to the Planning Commission, is engaged in providing residents in the country a Unique Identification number (called Aadhaar) linked...

-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision.  The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...